The advertising watchdog National Advertising Division said Wednesday that Apple advertising claimed Apple Intelligence ...

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...

Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling ...

BUFFALO, N.Y. — In January, Nicole Albanese, PharmD, clinical associate professor of pharmacy practice in the University at ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss. Some groups saw more pronounced effects than others.

Phoenix Suns star Devin Booker unveiled the latest edition of his Nike Book 1, Chevrolet vehicle collaboration on social ...

Cultured Magazine, the independent art, design and architecture magazine that broke onto the scene in 2012, is gearing up to ...

Through her Instagram community @blackgirlsgardening and a new book, Amber Grossman is looking to grow Black representation ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

The drugmaker used a 30-second advertising slot that aired during the Oscars ceremony on Sunday to encourage anyone considering sourcing tirzepatide – the active ingredient in Zepbound – to ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...